← All trials
NCT03706482
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2019
- Primary completion
- Jan 1, 2023
- Completion date
- Jan 1, 2033
- First posted
- —
- Last posted
- —
- Enrollment
- 210
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Karolinska InstituteLead sponsor
- Utrecht UniversityCollaborator
- University of LondonCollaborator
- University of CologneCollaborator
- Karolinska InstituteCollaborator
- Karolinska InstituteOverall official - principal investigator
- Leiden UniversityCollaborator
- Karolinska InstituteSponsor investigator
- Lund UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.